JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2226
Companhia Siderúrgica Nacional
SID
$1.66B
| $7.12M | ﹤0.01% |
1,731,343
-1,238,110
| -42% | -$3.9M |
2018 Q2
3 quarters
|
|
2227
CALL
Axsome Therapeutics
AXSM
$9.16B
| $7.12M | ﹤0.01% |
+500,000
| New | +$4.64M |
2019 Q1
0 quarters
|
|
|
FFIC
2228
DELISTED
Flushing Financial
FFIC
| $7.1M | ﹤0.01% |
323,949
-7,141
| -2% | -$161K |
2013 Q2
23 quarters
|
|
|
AVNS
2229
DELISTED
Avanos Medical
AVNS
| $7.1M | ﹤0.01% |
166,268
+60,310
| +57% | +$2.7M |
2014 Q4
17 quarters
|
|
2230
PTC
PTC
$21B
| $7.1M | ﹤0.01% |
76,989
-40,458
| -34% | -$3.58M |
2013 Q2
23 quarters
|
|
|
MYOK
2231
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $7.09M | ﹤0.01% |
136,336
+24,341
| +22% | +$1.12M |
2016 Q1
12 quarters
|
|
2232
Vipshop
VIPS
$6.05B
| $7.08M | ﹤0.01% |
881,981
-771,133
| -47% | -$5.46M |
2013 Q3
22 quarters
|
|
2233
Royal Gold
RGLD
$20B
| $7.07M | ﹤0.01% |
77,790
-92,972
| -54% | -$8.12M |
2013 Q2
23 quarters
|
|
|
ROCC
2234
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $7.06M | ﹤0.01% |
160,167
-172,712
| -52% | -$9.25M |
2016 Q4
9 quarters
|
|
2235
WisdomTree US MidCap Dividend Fund
DON
$3.82B
| $7.06M | ﹤0.01% |
197,237
-13,000
| -6% | -$454K |
2013 Q2
23 quarters
|
|
|
BEAT
2236
DELISTED
BioTelemetry, Inc.
BEAT
| $7.03M | ﹤0.01% |
112,203
+8,277
| +8% | +$569K |
2016 Q3
10 quarters
|
|
|
EPAY
2237
DELISTED
Bottomline Technologies Inc
EPAY
| $7.02M | ﹤0.01% |
140,234
-1,622
| -1% | -$78.3K |
2015 Q2
15 quarters
|
|
2238
Avis
CAR
$3.99B
| $7.01M | ﹤0.01% |
201,007
-171,309
| -46% | -$5.13M |
2013 Q2
23 quarters
|
|
2239
Independent Bank Corp
IBCP
$798M
| $6.99M | ﹤0.01% |
325,152
+4,251
| +1% | +$95.5K |
2015 Q3
14 quarters
|
|
2240
CALL
Tandem Diabetes Care
TNDM
$1.14B
| $6.99M | ﹤0.01% |
110,000
-61,000
| -36% | -$3.2M |
2018 Q3
2 quarters
|
|
2241
Hurco Companies Inc
HURC
$144M
| $6.98M | ﹤0.01% |
172,969
+66,679
| +63% | +$2.64M |
2013 Q2
23 quarters
|
|
|
TIER
2242
DELISTED
TIER REIT, Inc.
TIER
| $6.97M | ﹤0.01% |
243,181
-293,409
| -55% | -$6.97M |
2016 Q4
9 quarters
|
|
2243
CALL
Corning
GLW
$145B
| $6.97M | ﹤0.01% |
210,500
-343,200
| -62% | -$11.3M |
2017 Q4
5 quarters
|
|
2244
Eagle Materials
EXP
$5.29B
| $6.94M | ﹤0.01% |
82,364
+13,129
| +19% | +$948K |
2013 Q2
23 quarters
|
|
2245
Sea Limited
SE
$58.4B
| $6.93M | ﹤0.01% |
+294,513
| New | +$5.16M |
2019 Q1
0 quarters
|
|
2246
Alpha and Omega Semiconductor
AOSL
$886M
| $6.92M | ﹤0.01% |
601,457
-14,627
| -2% | -$162K |
2013 Q2
23 quarters
|
|
|
LM
2247
DELISTED
Legg Mason, Inc.
LM
| $6.92M | ﹤0.01% |
252,910
+129,930
| +106% | +$3.73M |
2013 Q2
23 quarters
|
|
|
LHCG
2248
DELISTED
LHC Group LLC
LHCG
| $6.91M | ﹤0.01% |
62,305
+32,400
| +108% | +$3.46M |
2016 Q2
11 quarters
|
|
2249
The Bancorp
TBBK
$2.01B
| $6.88M | ﹤0.01% |
851,938
-978
| -0.1% | -$8.46K |
2017 Q3
6 quarters
|
|
2250
PUT
Ovintiv
OVV
$17.1B
| $6.88M | ﹤0.01% |
+190,000
| New | +$6.51M |
2019 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.